In March of this year, the FDA released a Drug Safety Communication concerning the increased risk of serious pancreatitis in patients without a gallbladder who use the irritable bowel syndrome drug, Viberzi (eluxadoline). Viberzi is a relatively new drug manufactured by Allergan used to treat irritable bowel syndrome in adults when the main … [Read more...]